Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma

A. Loglio; M. Viganò; G. Grossi; S. Labanca; M. Goldaniga; A. Pompa; L. Farina; M. Rumi; P. Corradini; F. Facchetti; G. Lunghi; L. Baldini; P. Lampertico

doi:10.1016/j.dld.2018.08.024

Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma

A. Loglio, M. Viganò, G. Grossi, S. Labanca, M. Goldaniga, A. Pompa, L. Farina, M. Rumi, P. Corradini, F. Facchetti, G. Lunghi, L. Baldini, P. Lampertico

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	419-424
Number of pages	6
Journal	Digestive and Liver Disease
Volume	51
Issue number	3
DOIs	https://doi.org/10.1016/j.dld.2018.08.024
Publication status	Published - 2019

Access to Document

10.1016/j.dld.2018.08.024

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054427041&doi=10.1016%2fj.dld.2018.08.024&partnerID=40&md5=d536436074f64ba944fab7cc16d83edd

Cite this

Loglio, A., Viganò, M., Grossi, G., Labanca, S., Goldaniga, M., Pompa, A., Farina, L., Rumi, M., Corradini, P., Facchetti, F., Lunghi, G., Baldini, L., & Lampertico, P. (2019). Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma. Digestive and Liver Disease, 51(3), 419-424. https://doi.org/10.1016/j.dld.2018.08.024

Loglio, A, Viganò, M, Grossi, G, Labanca, S, Goldaniga, M, Pompa, A, Farina, L, Rumi, M, Corradini, P , Facchetti, F , Lunghi, G , Baldini, L & Lampertico, P 2019, 'Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma', Digestive and Liver Disease, vol. 51, no. 3, pp. 419-424. https://doi.org/10.1016/j.dld.2018.08.024

@article{65d33985bea847849ed32ffc991e2a5e,

title = "Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma",

author = "A. Loglio and M. Vigan{\`o} and G. Grossi and S. Labanca and M. Goldaniga and A. Pompa and L. Farina and M. Rumi and P. Corradini and F. Facchetti and G. Lunghi and L. Baldini and P. Lampertico",

note = "Cited By :1 Export Date: 24 February 2020",

year = "2019",

doi = "10.1016/j.dld.2018.08.024",

language = "English",

volume = "51",

pages = "419--424",

journal = "Digestive and Liver Disease",

issn = "1590-8658",

publisher = "Elsevier B.V.",

number = "3",

}

TY - JOUR

T1 - Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma

AU - Loglio, A.

AU - Viganò, M.

AU - Grossi, G.

AU - Labanca, S.

AU - Goldaniga, M.

AU - Pompa, A.

AU - Farina, L.

AU - Rumi, M.

AU - Corradini, P.

AU - Facchetti, F.

AU - Lunghi, G.

AU - Baldini, L.

AU - Lampertico, P.

N1 - Cited By :1 Export Date: 24 February 2020

PY - 2019

Y1 - 2019

U2 - 10.1016/j.dld.2018.08.024

DO - 10.1016/j.dld.2018.08.024

M3 - Article

VL - 51

SP - 419

EP - 424

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 3

ER -